Growth Investors & VC Firms in Netherlands

102 firms in this list, with a median first check of $1.6M. 21 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
NO Northzone EPJZJSMK46 people · Leads rounds	88🔒	London	GB	Seed–Growth	$1M – $50M	+ Add to CRM
QE QED Investors AGBCCVCR46 people · Leads rounds	88🔒	Alexandria	US	Seed–Growth	$30K – $25M	+ Add to CRM
AN Antler DMFBJSMG49 people · Leads rounds	88🔒	Singapore	SG	Pre-Seed–Growth	$3M – $10M	+ Add to CRM
AR Argos Wityu FHGLJAJP76 people	88🔒	Paris	FR	Growth	—	+ Add to CRM
NP NPM Capital N.V. BCAMHCMK65 people	88🔒	Amsterdam	NL	Growth	$32M – $320M	+ Add to CRM
BO BOM DVBMBVEC18 people · Follows rounds	88🔒	Tilburg	NL	Pre-Seed–Growth	$540K – $5.4M	+ Add to CRM
DA Dawn Capital LLP HOJBNFDC41 people · Leads rounds	88🔒	London	GB	Seed–Growth	$317.5K – $6.3M	+ Add to CRM
AT Atomico NZBBCAHT48 people · Follows rounds	88🔒	London	GB	Seed–Late Stage	—	+ Add to CRM
GE General Atlantic AGACACAF35 people · Leads rounds	88🔒	New York	US	Series B–Late Stage	$10M – $1B	+ Add to CRM
NV NV NOM AVMDSMAW27 people	88🔒	Groningen	NL	Seed–Growth	—	+ Add to CRM
ME Metaplanet JTRMSBUJ4 people · Follows rounds	88🔒	Tallinn	EE	Seed–Late Stage	$500K – $10M	+ Add to CRM
B2 b2venture AGCSDFFS36 people · Follows rounds	88🔒	Berlin	DE	Pre-Seed–Late Stage	$270K – $5.4M	+ Add to CRM
HO Holland Capital EPHVHGJF43 people	88🔒	Amsterdam	NL	Seed–Late Stage	—	+ Add to CRM
KO Korys DCGAHSBD32 people	88🔒	Halle	BE	Series A–Late Stage	$5.4M	+ Add to CRM
EQ EQT Life Sciences PFAPBJBH37 people · Leads rounds	88🔒	Luxembourg	LU	Seed–Late Stage	$11M – $66M	+ Add to CRM
IN Innovation Industries HDNSCGDK25 people · Follows rounds	88🔒	Amsterdam	NL	Seed–Late Stage	$2.2M – $54M	+ Add to CRM
M M Ventures HGBACUDF8 people · Follows rounds	88🔒	Los Angeles	US	Seed–Growth	$10.8M	+ Add to CRM
HE HealthCap MSTRVMAF30 people	88🔒	Stockholm	SE	Seed–Growth	—	+ Add to CRM
EV EV Private Equity HTOMEGES15 people	88🔒	Stavanger	NO	Seed–Growth	$5M – $30M	+ Add to CRM
SM SmartFin BLJIHHSD23 people	88🔒	Brussels	BE	Seed–Late Stage	$1.1M – $55M	+ Add to CRM
EQ Equistone Partners Europe	88🔒	London	GB	Growth	$27M – $216M	+ Add to CRM
KL Klar Partners CJFBAMAK30 people	88🔒	London	GB	Growth–Late Stage	$27.5M – $275M	+ Add to CRM
ET ETF Partners PSPHFBLR24 people	88🔒	London	GB	Series A–Growth	$5.4M – $16.2M	+ Add to CRM
SH SHIFT Invest BLFFGVJB10 people · Follows rounds	88🔒	Amstelveen	NL	Pre-Seed–Growth	$270K – $3.3M	+ Add to CRM

Northzone

LondonSeed–Growth$1M – $50M

EPJZJSMK46 people

QED Investors

AlexandriaSeed–Growth$30K – $25M

AGBCCVCR46 people

Antler

SingaporePre-Seed–Growth$3M – $10M

DMFBJSMG49 people

Argos Wityu

ParisGrowth

FHGLJAJP76 people

NPM Capital N.V.

AmsterdamGrowth$32M – $320M

BCAMHCMK65 people

BOM

TilburgPre-Seed–Growth$540K – $5.4M

DVBMBVEC18 people

Dawn Capital LLP

LondonSeed–Growth$317.5K – $6.3M

HOJBNFDC41 people

Atomico

LondonSeed–Late Stage

NZBBCAHT48 people

General Atlantic

New YorkSeries B–Late Stage$10M – $1B

AGACACAF35 people

NV NOM

GroningenSeed–Growth

AVMDSMAW27 people

Metaplanet

TallinnSeed–Late Stage$500K – $10M

JTRMSBUJ4 people

b2venture

BerlinPre-Seed–Late Stage$270K – $5.4M

AGCSDFFS36 people

Holland Capital

AmsterdamSeed–Late Stage

EPHVHGJF43 people

Korys

HalleSeries A–Late Stage$5.4M

DCGAHSBD32 people

EQT Life Sciences

LuxembourgSeed–Late Stage$11M – $66M

PFAPBJBH37 people

Innovation Industries

AmsterdamSeed–Late Stage$2.2M – $54M

HDNSCGDK25 people

M Ventures

Los AngelesSeed–Growth$10.8M

HGBACUDF8 people

HealthCap

StockholmSeed–Growth

MSTRVMAF30 people

EV Private Equity

StavangerSeed–Growth$5M – $30M

HTOMEGES15 people

SmartFin

BrusselsSeed–Late Stage$1.1M – $55M

BLJIHHSD23 people

Equistone Partners Europe

LondonGrowth$27M – $216M

Klar Partners

LondonGrowth–Late Stage$27.5M – $275M

CJFBAMAK30 people

ETF Partners

LondonSeries A–Growth$5.4M – $16.2M

PSPHFBLR24 people

SHIFT Invest

AmstelveenPre-Seed–Growth$270K – $3.3M

BLFFGVJB10 people

Data sourced from public filings and firms' own websites — see our methodology.